Table 2.

Trial key inclusion criteria

ACS acute coronary syndrome, BP blood pressure, CAD coronary artery disease, CKD chronic kidney disease, CV cardiovascular, ECG electrocardiogram, eCVD established cardiovascular disease, HbA1c haemoglobin A1c (glycated haemoglobin), HDL high-density lipoprotein, HF heart failure, LDL low-density lipoprotein, LV left ventricle, MI myocardial infarction, NYHA New York Heart Association classification, PAD peripheral artery disease, STEMI segment elevation myocardial infarction, TIA transient ischemic attack, UA unstable angina, Grey shade inclusion criteria adopted in the trialA – age 50–54 only; B—≥ 50 years; C – 55–59 years; *estimated glomerular filtration rate < 60 mL per minute per 1.73 m²